Cannabis Sativa Inc.

Unaudited ProForma Combined Balance Sheets

CBDS             June 30, 2017

PrestoCorp             June 30, 2017

Pro Forma Adjustments

Ref

Pro Forma Balance

Assets

Cash

$441,469 

$45,612 

$487,081 

Accounts receivable

2,128 

1,500 

3,628 

Inventory

18,566 

18,566 

Other current assets

81,386 

7,065 

88,451 

Total Current Assets

543,549 

54,177 

597,726 

Equipment, net

3,534 

8,770 

12,304 

Intangible assets

3,217,011 

5,463,000 

(1) 

8,680,011 

Other long term assets

50,742 

50,742 

Total Assets

$3,814,836 

$62,947 

$5,463,000 

$9,340,783 

Liabilities and Stockholders' Equity (Deficit)

Current Liabilities

Accounts payable & accrued expenses

715,347 

36,149 

751,496 

Income taxes payable

- 

3,998 

3,998 

Related party payable

302,793 

4,226 

307,019 

Total current liabilities

1,018,140 

44,373 

1,062,513 

Stockholders' Equity (Deficit)

Preferred Stock $0.001 par value; 5,000,000 shares authorized,

732,018 issued and outstanding

732 

732 

Common Stock, $0.0001 par value, 5,000 shares authorized,

- 

- 

- 

issued and outstanding

Common Stock, $0.001 par value, 45,000,000 shares authorized,

19,255,796 issued and outstanding

19,524 

19,524 

Additional Paid in Capital

65,751,392 

- 

 2,351,574

(3)(4)

68,102,966 

  Retained earnings (accumulated deficit)

  (63,154,146)

         18,574

         (18,574)

(4)

   (63,154,146)

Non-controlling Interest

         179,194

                  3,130,000   

          3,309,194

  Total Stockholders' Equity (Deficit)

      2,796,696

         18,574

     5,463,000

      -   

       8,278,270

Total Liabilities and Stockholders' Equity (Deficit)

 $ 3,814,836

 $ 62,947

 $ 5,463,000

 $ 9,340,783

References (2017 Balance Sheet):

1.    

Based on preliminary purchase price allocation to intangible assets

2.    

The purchase price includes an earn-out based on future performance of the Company with the

maximum amounts payable of $510,000 in 2019 and $510,000 in 2020 if certain revenue and income

milestones are achieved.

3.   

 Estimated fair value of equiity issued in the purchase. Such valuation is pending final allocation.

4.   

Elimination of historical earnings of PrestoCorp to Paid-in-capital.

Cannabis Sativa, Inc.

Unaudited ProForma Combined Statement of Income

For the Year Ended December 31, 2016

For the Year Ended December 31, 2016

CBDS

PrestoCorp

Proforma Adjustments

Proforma Balance

Revenues

29,168  

517,474 

546,642  

Expenses

3,183,767  

494,707 

300,000(1) 

3,978,474  

Minority interest

(21,223) 

- 

(11,156)(2) 

(32,379) 

Net Loss

$(3,133,376) 

$22,767 

$(288,844) 

$(3,399,453) 

Adjustments:

1.) To record amortization of PrestoCorp intangibles of $300,000 for the year.

2.) To eliminate the non-controlling interest in the net income for the year.

Cannabis Sativa, Inc.

Unaudited ProForma Statement of Income

For the Six Months Ended June 30, 2017

CBDS

June 30, 2017

PrestoCorp

June 30, 2017

Proforma Adjustments

Proforma Balance

Revenues

3,046  

489,246 

492,292  

Expenses

3,970,619  

486,588 

150,000(1) 

4,607,207  

Loss attributable to minority interests

(39,758) 

- 

(1,303)(2) 

(41,061) 

Net Loss

$(3,927,815) 

$2,658 

$(151,303) 

$(4,076,459) 

Adjustments:

1.) To record amortization of tPrestoCorp intangibles of $150,000 for the six months plus $4,000 of interest

expense on a loan to Cannabis Sativa from a related party of $200,000.

2.) To eliminate the non-controlling interest in net income